WOCKPHARMA — Wockhardt Share News
0.000.00%
Last trade - 00:00- IN₹317.66bn
- IN₹337.11bn
- IN₹33.73bn
Brief: India's Wockhardt Sept-Qtr Consol Loss After Tax 2.07 Bln Rupees
Brief: Wockhardt Announces Successful Initiation Of Global Phase 3 Clinical Study Of Novel Antibiotic
Brief: India's Wockhardt June-Qtr Consol Net Loss Widens
Brief: Glenmark Pharmaceuticals Inc USA Continues To Expand Its Over-The-Counter (OTC) Portfolio With Acquisition Of Approved Andas From Wockhardt Limited
Brief: Glenmark Pharma U.S. Unit Buys Approved ANDAs From Wockhardt
Brief: Wockhardt Appoints Deepak Madnani As CFO
March Quarter Consol Net Loss 2.58 Billion Rupees
Brief: Wockhardt Appoints Pramod Gupta As CFO
Brief: Wockhardt Approves Rights Issue For Amount Aggregating To 7.48 Bln Rupees
Brief: Wockhardt Gets CDSCO Nod To Export Up To 100 Mln Doses Of Sputnik Vaccines
Brief: India's Wockhardt Dec-Quarter Loss Narrows
Brief: Wockhardt Approves Issue Of Equity Shares Via Rights Issue For Amount Not Exceeding 10 Bln Rupees
Brief: Wockhardt To Consider Fund Raising Options
India's Wockhardt rises as Sept-qtr profit surges over 9-fold
Brief: Wockhardt Says Media Report Pertaining To Proposed Stake Sale By Co Purely Speculative
Wockhardt jumps on tie-up with China's Jemincare for respiratory antibiotic
Brief: Wockhardt, Jemincare Partner For Respiratory Antibiotic Nafithromycin
India's Wockhardt jumps on Sputnik vaccine deal with Dubai's Enso
Brief: Wockhardt - In Process Of Negotiating Manufacturing Options For Covid -19 Vaccine